Cintas Corp. (CTAS) delivered mixed results in Q4 FY2026 on revenue of $2.9B versus the $2.9B estimate (+8.9% YoY) and EPS of $1.29. The next Cintas Corp. (CTAS) earnings date is Sep 23, 2026. Below is the full Cintas Corp. earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
Cintas Corp. (CTAS) Earnings Analysis — key stats
Next earnings date
Sep 23, 2026
Latest reported quarter
Q4 FY2026
Earnings verdict
Mixed
EPS beat rate
4 of last 8 (quarters above estimate)
Avg next-day move
±4.7% (over the last 8 reports)
Post-earnings direction
Up 6 / Down 2 (of the last 8 reports)
Implied move (next report)
±6.9% (options-derived · into Sep 23, 2026)
Institutional ownership
90.3% (13F as of 2026-06-30)
Top 10 holders
30.5% (of shares outstanding)
Insider activity
7 buys / 5 sells (recent Form 4 filings)
Revenue
$2.9B (vs $2.9B est · +1.1% surprise · +8.9% YoY)
EPS
$1.29 (vs $1.24 est · +4.0% surprise · +14.4% YoY)
Share price
$207.40 (+1.8%)
Market cap
$83.0B
Cintas Corp. (CTAS) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q1 FY2027
$2.9B vs $2.9B est
$1.29 vs $1.24 est
+4.0%
+11.9%
Mixed
Q4 FY2026
$2.8B vs $2.8B est
$1.24 vs $1.24 est
+0.0%
-5.2%
In line
Q3 FY2026
$2.8B vs $2.8B est
$1.21 vs $1.20 est
+0.8%
+0.1%
In line
Q2 FY2026
$2.7B vs $2.7B est
$1.20 vs $1.19 est
+0.8%
+0.7%
In line
Q1 FY2026
$2.7B vs $2.6B est
$1.09 vs $1.07 est
+1.9%
+3.7%
In line
Q4 FY2025
$2.6B vs $2.6B est
$1.13 vs $1.07 est
+5.6%
+6.6%
Mixed
Q3 FY2025
$2.6B vs $2.6B est
$1.09 vs $1.01 est
+7.9%
-8.5%
Mixed
Q2 FY2025
$2.5B vs $2.5B est
$1.10 vs $0.95 est
+15.8%
+1.1%
Mixed
Top institutional holders
Holder
% outstanding
Shares
Value
QoQ change
Blackrock, INC.
6.6%
26.6M
$4.5B
-1.5%
Vanguard Capital Management LLC
5.5%
22.2M
$3.8B
+0.6%
State Street Corp
3.9%
15.8M
$2.7B
+2.8%
Invesco Ltd.
3.4%
13.6M
$2.3B
+61.8%
Vanguard Portfolio Management LLC
3.3%
13.4M
$2.3B
+1.1%
Geode Capital Management, LLC
2.4%
9.5M
$1.6B
+0.3%
Fmr LLC
1.6%
6.3M
$1.1B
-8.8%
Price T Rowe Associates INC /Md/
1.4%
5.8M
$978.1M
+0.2%
Goldman Sachs Group INC
1.2%
4.7M
$799.1M
+19.4%
Norges Bank
1.1%
4.4M
$741.8M
+100.0%
Recent insider transactions
Insider
Role
Date
Type
Shares
Value
Rozakis Jim
officer: President & COO
2026-08-10
Sell
4K
$819151
Schneider Todd M.
director, officer: CEO and Director
2026-08-10
Buy
58K
$11.7M
Schneider Todd M.
director, officer: CEO and Director
2026-08-10
Sell
36K
$7.2M
FARMER SCOTT D
director, officer: Executive Chairman
2026-08-10
Buy
830
$168249
FARMER SCOTT D
director, officer: Executive Chairman
2026-08-10
Sell
16K
$3.2M
Garula Scott
officer: EVP & CFO
2026-08-10
Buy
11K
$2.2M
Garula Scott
officer: EVP & CFO
2026-08-10
Sell
3K
$599616
Denton David Brock
officer: EVP, Secretary & Gen Counsel
2026-08-10
Buy
370
$75003
What you'll find
Next Cintas Corp. (CTAS) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Cintas Corp. reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Cintas Corp. (CTAS)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Cintas Corp.'s next earnings date?
Cintas Corp.'s (CTAS) next scheduled earnings date is Sep 23, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Cintas Corp. (CTAS) beat or miss earnings?
In Q4 FY2026, Cintas Corp. (CTAS) posted mixed results — revenue of $2.9B versus the $2.9B estimate (+1.1% surprise) and EPS of $1.29 versus $1.24 expected (+4.0% surprise). Magnisto decodes every Cintas Corp. (CTAS) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does Cintas Corp. beat earnings estimates?
Over its last 8 reported quarters, Cintas Corp. (CTAS) beat Wall Street EPS estimates 4 times, most recently a mixed result in Q1 FY2027. Magnisto tracks every Cintas Corp. (CTAS) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does Cintas Corp. stock move after earnings?
Over its last 8 quarterly reports, Cintas Corp. (CTAS) moved an average of ±4.7% the day after earnings — ranging from -8.5% (Q3 FY2025) to +11.9% (Q1 FY2027). The stock rose after 6 of those 8 reports and fell after 2. Heading into its next report on Sep 23, 2026, options-implied volatility is pricing in a move of roughly ±6.9% (derived). Magnisto tracks the realized post-earnings move for every Cintas Corp. (CTAS) quarter alongside the beat/miss verdict — past moves don't predict the next one.
Who are the largest shareholders of Cintas Corp.?
Institutions hold about 90.3% of Cintas Corp.'s (CTAS) shares outstanding as of the 2026-06-30 13F quarter. Its largest institutional holders include Blackrock, INC. (6.6%), Vanguard Capital Management LLC (5.5%), State Street Corp (3.9%). Magnisto lists Cintas Corp.'s (CTAS) top 13F holders with each stake size and its quarter-over-quarter change.
Are insiders buying or selling Cintas Corp. (CTAS)?
In the most recent Form 4 filings Magnisto tracks, Cintas Corp. (CTAS) insiders recorded 7 purchases and 5 sales — net buying. Insider transactions are one signal among many and are often routine (option exercises or scheduled 10b5-1 sales), so Magnisto shows the raw feed for you to judge.
What is the forecast for Cintas Corp. (CTAS) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Cintas Corp. (CTAS), anchored to the current $207.40 share price, so you can weigh the bull, base and bear cases for Cintas Corp. side by side.
Is Cintas Corp. (CTAS) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Cintas Corp. fits your own thesis and risk profile. This is research, not investment advice.